GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GH Research PLC (STU:1KA) » Definitions » Quick Ratio

GH Research (STU:1KA) Quick Ratio : 17.23 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GH Research Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. GH Research's quick ratio for the quarter that ended in Dec. 2024 was 17.23.

GH Research has a quick ratio of 17.23. It generally indicates good short-term financial strength.

The historical rank and industry rank for GH Research's Quick Ratio or its related term are showing as below:

STU:1KA' s Quick Ratio Range Over the Past 10 Years
Min: 4.85   Med: 24.26   Max: 101.8
Current: 17.23

During the past 6 years, GH Research's highest Quick Ratio was 101.80. The lowest was 4.85. And the median was 24.26.

STU:1KA's Quick Ratio is ranked better than
91.15% of 1492 companies
in the Biotechnology industry
Industry Median: 3.38 vs STU:1KA: 17.23

GH Research Quick Ratio Historical Data

The historical data trend for GH Research's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GH Research Quick Ratio Chart

GH Research Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Quick Ratio
Get a 7-Day Free Trial 24.06 101.79 37.08 24.49 17.23

GH Research Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.49 22.06 19.60 15.83 17.23

Competitive Comparison of GH Research's Quick Ratio

For the Biotechnology subindustry, GH Research's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GH Research's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GH Research's Quick Ratio distribution charts can be found below:

* The bar in red indicates where GH Research's Quick Ratio falls into.


;
;

GH Research Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

GH Research's Quick Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Quick Ratio (A: Dec. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(147.285-0)/8.55
=17.23

GH Research's Quick Ratio for the quarter that ended in Dec. 2024 is calculated as

Quick Ratio (Q: Dec. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(147.285-0)/8.55
=17.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GH Research  (STU:1KA) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


GH Research Quick Ratio Related Terms

Thank you for viewing the detailed overview of GH Research's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GH Research Business Description

Traded in Other Exchanges
Address
Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

GH Research Headlines

No Headlines